Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion

Retina

Volumn 33, Issue 6, 2013, Pages 1227-1231

  Sharareh, Behnam ^a,b   Gallemore, Ron ^a   Taban, Mehran ^a   Onishi, Spencer ^a   Wallsh, Josh ^a  

^a Retina Macula Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anti VEGF; Avastin; bevacizumab; dexamethasone; macular edema; Ozurdex; resistance; retinal vein occlusion

Indexed keywords

BEVACIZUMAB; BLOOD CLOTTING FACTOR 5 LEIDEN; DEXAMETHASONE; EYE DROPS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; GENE MUTATION; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAOCULAR PRESSURE; LUPUS VULGARIS; MACULAR THICKNESS; MALE; OPHTHALMOLOGICAL IMPLANT; RETINA FOVEA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VISUAL ACUITY;

EID: 84878899977     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31827c53a0     Document Type: Article

References (15)

1. Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol 2010;4:809-816.
2. Wang P, Zhu F, Konstantopoulos K, et al. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinasedependent NF-kB activation. Am J Physiol Cell Physiol 2010;298:C1445-C1456.
3. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-282.
4. Prager F, Michaels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular edema secondary to retinal vein occlusion: 12- month results of a prospective clinical trial. Br J Ophthalmol 2009;93:452-456.
5. Gallemore RP. NSAIDs in treatment of retinal disorders. Rev Ophthalmol 2006;13:11.
6. Matsumoto Y, Freund B, Peiretti E, et al. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007;27:426-431. (Pubitemid 46624281)
7. Yasuda S, Kondo M, Kachi, et al. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 2011;31:1075-1082.
8. Chang-Lin JE, Attar M, Acheampong AA, et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011;52:80.
9. Ooto S, Hangai M, Sakamoto A, et al. Three-dimensional profile of macular retinal thickness in normal Japanese eyes. Invest Ophthalmol Vis Sci 2009. doi:10.1167/iovs.09-4047.
10. Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425. (Pubitemid 46624280)
11. Haller JA, Bandello F, Belfort R Jr, et al. Randomized, shamcontrolled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.e3.
12. Chan A, Duker JS, Ko TH, et al. Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 2006;124:193-198. doi: 10:1001/archopht.124.2.193. (Pubitemid 43247068)
13. Herrero-Vanrell R, Cardillo JA, Kuppermann BD. Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 2011;5: 139-146.
14. Chen CH, Chen YH, Wu PC, et al. Treatment of branch retinal vein occlusion induced macular edema in treatment-naïve cases with a single intravitreal triamcinolone or bevacizumab injection. Chang Gung Med J 2010;33:424-435.
15. Kuppermann BD, Blumenkranz MS, Haller JA, et al; Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007;125:309-317. (Pubitemid 46425557)